CDKL5 Pilot Grant Program

This grant seeks grant applications that progress the discovery or development of treatments and/or cures for CDKL5 Deficiency Disorder. While the RFA is broad in scope, priority will be given to grants that cover the following areas:

1) Novel therapeutic approaches for CDD

2) Establishment of the link between molecular function of CDKL5 and disease pathophysiology

3) Systems biology and computational modeling approaches

4) Discovery and validation of CDKL5 biomarkers

Funding: $150,000 total 

Duration: 1 year

Research Authority due date: 17.2.23

LOI (required) due date: 24.2.23

Full proposal due date: 24.3.23